Mersana Therapeutics Inc (MRSN)
2.725
+0.14
(+5.62%)
USD |
NASDAQ |
May 17, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Cash and Short Term Investments (Quarterly): 183.15M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 183.15M |
| December 31, 2023 | 209.08M |
| September 30, 2023 | 240.99M |
| June 30, 2023 | 286.59M |
| March 31, 2023 | 273.92M |
| December 31, 2022 | 280.71M |
| September 30, 2022 | 290.13M |
| June 30, 2022 | 225.13M |
| March 31, 2022 | 230.06M |
| December 31, 2021 | 177.95M |
| September 30, 2021 | 191.71M |
| June 30, 2021 | 227.39M |
| March 31, 2021 | 228.43M |
| December 31, 2020 | 255.09M |
| September 30, 2020 | 270.94M |
| Date | Value |
|---|---|
| June 30, 2020 | 291.38M |
| March 31, 2020 | 78.43M |
| December 31, 2019 | 99.79M |
| September 30, 2019 | 112.00M |
| June 30, 2019 | 128.18M |
| March 31, 2019 | 137.28M |
| December 31, 2018 | 70.13M |
| September 30, 2018 | 86.06M |
| June 30, 2018 | 96.51M |
| March 31, 2018 | 107.96M |
| December 31, 2017 | 114.73M |
| September 30, 2017 | 133.38M |
| June 30, 2017 | 77.23M |
| March 31, 2017 | 88.52M |
| December 31, 2016 | 100.30M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
78.43M
Minimum
Mar 2020
291.38M
Maximum
Jun 2020
214.05M
Average
227.91M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 239.60M |
| Geron Corp | 443.05M |
| Insmed Inc | 595.73M |
| Altimmune Inc | 182.02M |
| InfuSystems Holdings Inc | 0.822M |